Mental Health DailyResearch. Evidence. Perspective.Published research on neuropathic pain.
In a 29-person randomized trial, 2 weeks of motor cortex rTMS lowered nerve pain after spinal cord injury more than sham. Depression and anxiety fell in the active group but did not beat sha…
Read articleA 2026 neuroscience review argues that chemotherapy-induced peripheral neurotoxicity should not be treated as a purely peripheral nerve problem: CIPN affects 70-90% of patients during chemot…
Read articleA 210-person randomized assessor-blinded trial found that adding weekly Hegu-point catgut embedding to gabapentin improved 4-week postherpetic-neuralgia response from 80.00% to 92.38%; compa…
Read articleA 2026 Taiwanese case series reported VAS pain drops in all 3 adults treated with pregabalin for type I complex regional pain syndrome: 9 to 5, 2 to 1, and 6 to 3 after doses of 75-150 mg/da…
Read articleA 2026 case series of 10 adults with refractory postherpetic neuralgia found: 3 of 8 patients responded to a spinal cord stimulation trial, 2 kept meaningful 24-month relief after implantati…
Read articleGabapentin is a drug that was formally approved in 1993 for the treatment of epilepsy. It is still commonly used as an anticonvulsant drug, generally as an adjunct. Roughly a decade later, t…
Read articleMarijuana is the most popular among illicit drugs in the world. Part of the reason that it is extremely popular has to do with the fact that people like what the drug does for them. In my op…
Read article
